Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PLAU | P00749 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3714098 | 0.71 | CA2 (0.50) | CPB2TDP1KMT2AMEN1TSHR | |
| SCHEMBL487579 | 0.70 | CPB2 (0.38) | CPB2TDP1KMT2AALDH1A1L3MBTL1 | |
| SCHEMBL1549300 | 0.70 | ALDH1A1 (0.36) | TDP1KMT2AALDH1A1MEN1 | |
| SCHEMBL2420113 | 0.70 | TAAR1 (0.50) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL20245754 | 0.70 | ALDH1A1 (0.35) | TDP1ALDH1A1L3MBTL1SMN1; SMN2 | |
| SCHEMBL3710578 | 0.69 | ALDH1A1 (0.50) | ALDH1A1NPC1RAB9ATSHRSMN1; SMN2 | |
| SCHEMBL10840981 | 0.68 | ALDH1A1 (0.36) | TDP1KMT2AALDH1A1MEN1 | |
| SCHEMBL22775209 | 0.68 | GRIA2 (0.50) | CPB2TDP1 | |
| SCHEMBL10282386 | 0.67 | ALDH1A1 (0.44) | ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL27764275 | 0.67 | ALDH1A1 (0.35) | TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8106212-B2 | Substituted enaminocarbonyl compounds | BAYER CROPSCIENCE AG (DE) | 2012-01-31 | — | — | US | disclosed |
| US-20090247551-A1 | SUBSTITUTED ENAMINOCARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247551-A1 | SUBSTITUTED ENAMINOCARBONYL COMPOUNDS | DDT, NPEPPS, L3MBTL4 | CPB2 684/4885TDP1 3443/4885KMT2A 1680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.